SMASHING in adolescents: Self-Management of Asthma Supported by Hospitals, Information and communication technology, Nurses and General practitioners

ISRCTN ISRCTN11633371
DOI https://doi.org/10.1186/ISRCTN11633371
Secondary identifying numbers N/A
Submission date
28/12/2006
Registration date
28/12/2006
Last edited
22/05/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Jacob K. Sont
Scientific

Department of Medical Decision Making, J10-86
Leiden University Medical Center
P.O. Box 9600
Leiden
2300 RC
Netherlands

Phone +31 (0)71 526 4578
Email j.k.sont@lumc.nl

Study information

Study designRandomised, controlled, parallel group, multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymSMASHING
Study objectivesA self-management programme guided by doctors and a specialist asthma nurse through information and communication technology will improve asthma related quality of life in a cost-effective way.
Ethics approval(s)Approval received from the local ethics committee (Commissie Medische Ethiek) on the 7th August 2006 (reference number: P06.110).
Health condition(s) or problem(s) studiedAsthma
InterventionPlease note that as of 06/02/2008 the anticipated end date of this trial was extended to 30/05/2009. The previous end date of this trial was 30/06/2008.

Information and Communication Technology (ICT)-supported care:
1. Asthma self-management education in small groups (two sessions per group) by trained asthma specialist nurse:
a. Discussion of ACQ and ATAQ data in order to assess present situation and electronic asthma action plan
b. Review medication devices technique and adherence
c. Plan next doctor visits as needed
2. Monitoring asthma control by lung
function and ACQ (input via website or SMS [text messaging]) with electronic data processing and feedback through computer via webpages with graphical presentation of data for patient and nurse
3. Virtual consulting room with asthma nurse via email and private messaging
4. Social support within a private chatbox and/or internet support group
5. Automated sending of reminders via email and/or SMS

Control group: usual care:
According to the Dutch General Practitioner (GP) guidelines, patients are invited to visit their general practitioner every three months in order to titrate medication to the lowest level that is needed to maintain control. This frequency can be lowered to one to two visits per year once control of asthma has been achieved. Thirty percent of general practices have nurse practitioners providing self-management education. Patients are referred to a pediatrician/pediatric pulmonologist if sufficient control is not achieved within three months. Exacerbations of asthma are treated by either pediatrician and general practitioner:
1. Advise to visit to general practitioner or pediatrician to assess present situation
2. Review medication devices technique and adherence
3. Issue and explain paper asthma action plan, monitoring of lung function with Piko-1 spirometer
4. Plan next doctor visits as needed
Intervention typeOther
Primary outcome measureHealth related quality of life as measured by the Pediatric Asthma Quality of Life Questionnaire (PAQLQ).
Secondary outcome measures1. Asthma control
2. Symptom free days
3. Exacerbations
4. Health care utilisation
5. Absence of work/school
6. Lung function
7. Exhaled nitric oxide
8. Medication use
9. Self-reported asthma management behaviour
10. Side effects
Overall study start date15/12/2006
Completion date30/05/2009

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit12 Years
Upper age limit17 Years
SexNot Specified
Target number of participants124
Key inclusion criteria1. Age 12 to 17 years
2. Doctors diagnosis of asthma
3. Mild to severe persistent asthma (patients who need inhaled corticosteroids as controller medication)
4. At least one asthma control problem (Asthma Therapy Assessment Questionnaire [ATAQ] score more than or equal to one or Asthma Control Questionnaire [ACQ] more than or equal to one)
5. Able to communicate in the Dutch language
Key exclusion criteriaPatients requiring oral corticosteroids as controller medication and patients with relevant comorbidity will be excluded.
Date of first enrolment15/12/2006
Date of final enrolment30/05/2009

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Department of Medical Decision Making, J10-86
Leiden
2300 RC
Netherlands

Sponsor information

Leiden University Medical Center (LUMC) (Netherlands)
Hospital/treatment centre

Funders

Funder type

Research organisation

Astmafonds (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2012 Yes No